Colchicine for CPPD: reducing pain and inflammation
Treatments studied
Part of Bones, joints & muscles clinical trials.
This trial tests if colchicine can reduce pain and swelling in people with CPPD (calcium pyrophosphate deposition disease), a type of arthritis. If you have had a swollen, red, or warm joint in the last 3 months and your pain is moderate or higher, this study may offer a possible treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have CPPD (a type of arthritis caused by calcium crystals in the joints).
- You have had at least one joint that is swollen, red, or warm to the touch in the past 3 months.
- Your pain level at screening is at least 30 on a 0-100 scale (0 = no pain, 100 = worst pain).
- You are 40 years or older.
- You are not currently taking colchicine, or you are willing to stop taking it for 30 days before starting the study.
- You do not have gout, rheumatoid arthritis, psoriatic arthritis, or cirrhosis.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether taking colchicine around the time of surgery can reduce bad events after surgery in people at higher heart risk. It focuses on helping prevent complications related to inflammation after an operation.
This study looks at calcium pyrophosphate deposition (CPPD) disease, a condition where crystals build up in joints and cause pain and swelling. It aims to learn more about how the disease acts in both sudden attacks and long-term joint problems, which could help improve treatment.
This trial tests whether a drug called tocilizumab can reduce joint pain and swelling in people with chronic CPPD (calcium pyrophosphate deposition disease), a type of arthritis. It is for those who have not gotten enough relief from standard treatments.
This trial tests whether colchicine, a drug that reduces inflammation, can help prevent further heart problems or strokes in people with moderate chronic kidney disease. You may be eligible if you have kidney disease and have had a heart attack, stroke, or related event in the past.
This trial tests if the anti-inflammatory drug colchicine can help people with non-severe coronary artery plaque seen on a CT scan. It may be an option if you have stable chest pain or related symptoms and your heart arteries are partly blocked but not severely.
This study tests whether a daily low dose of colchicine, a medicine used for gout and inflammation, can reduce inflammation and improve blood vessel and bone health in people with chronic kidney disease. It might help prevent complications like heart disease and weak bones.
Hear when a new CPPD - Calcium Pyrophosphate Deposition Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.